Lymphomas
A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination with Rituximab in Participants with Newly Diagnosed Advanced Stage Follicular Lymphoma (GOLSEEK-2)(CA0731022)
- Details
ClinicalTrials.gov ID:
NCT06425302
Diagnosis Type:
NA
USOR Number:
- Address
,
P: